Skip to search formSkip to main contentSkip to account menu

OP 1206

Known as: OP-1206 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Antitumor drugs like methotrexate cause damage to the small intestine, resulting in malabsorption. The present study evaluated… 
1999
1999
5-Fluorouracil (5-FU) often causes the gastrointestinal toxicity, including enterocolitis. We investigated effects of OP-1206… 
1997
1997
Prostaglandin E1 (PGE1) is commonly used in therapy for obstructive diseases, including ischemic retinopathy, in which… 
1996
1996
The effect of OP-1206, a prostaglandin E1 derivative, on cauda equina function was analyzed in a model for acute cauda equina… 
1995
1995
Nerve ischemia induces wallerian degeneration and peripheral neuropathy, and nerve constriction injury induces thermal… 
1988
1988
The present study investigates the inhibitory action of the PGE1-analogue OP-1206 on stimulated LTB4 release from human PMN. In… 
1984
1984
In order to assess the clinical effectiveness of an oral prostaglandin E1 derivative, OP-1206, five patients with chronic… 
1980
1980
Effects of OP 1206 were studied on the cardiovascular system and platelet functions to assess OP 1206 as an antianginal agent. OP…